ShockwaveIVL Profile Banner
Shockwave Medical Profile
Shockwave Medical

@ShockwaveIVL

Followers
7K
Following
2K
Media
3K
Statuses
4K

Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊 Important Safety Information: https://t.co/x46wohk9Gd

Santa Clara, CA
Joined July 2017
Don't wanna be here? Send us removal request.
@ShockwaveIVL
Shockwave Medical
6 hours
Reach beyond the ankle with Shockwave E8, the new peripheral workhorse IVL catheter. Watch the video to hear from Dr Ash Patel how Shockwave E8 fits in his daily practice and helps him tackle hostile BTK lesions in a safe & effective manner. . US Rx
Tweet media one
0
0
0
@ShockwaveIVL
Shockwave Medical
12 hours
For International Physicians:🔬 New Data Coming to ESC 2025 . We’re proud to highlight a key session at ESC 2025 where important new real-world data on the #ShockwaveReducer will be presented: . 🔵Save the Date .🕒 August 31 | 15:20 CEST .📢 “The use of the Coronary Sinus
Tweet media one
0
1
3
@ShockwaveIVL
Shockwave Medical
3 days
Congratulations to Dr. Salvatore Mannino and the team at Wellstar Kennestone in Marietta, Georgia for joining the growing number of #COSIRAII enrolling sites and completing their 1st single-arm patient for the trial. To learn more about the COSIRA-II trial and the
Tweet media one
0
1
1
@ShockwaveIVL
Shockwave Medical
4 days
Join us on September 12th for a full day of live CTO cases broadcast straight from Emory University Hospital! Register now to take part in this year’s CHiP SHOT Fellows Program virtual event: Drs. William Nicholson, Jal Khatri, and Kevin Croce are paid
Tweet media one
0
0
3
@ShockwaveIVL
Shockwave Medical
4 days
Mark your calendars for this can’t-miss BTK webinar! Join us on September 9 at 8:30 pm ET for a virtual case review featuring challenging cases from Drs. Paul Foley and Mazin Foteh. Dr. Leigh Ann O’Banion (@limbsalvagedr) will moderate the event, sparking discussion about best
Tweet media one
0
0
2
@ShockwaveIVL
Shockwave Medical
5 days
Kudos to Dr. Adam Frank, the NCH Rooney Heart Institute, and NCH Research Institute teams for their participation in the COSIRA-II study, joining the growing number of #COSIRAII enrolling sites and completing their 1st randomized patient and ANOCA single - arm patient in the
Tweet media one
0
1
1
@ShockwaveIVL
Shockwave Medical
6 days
We’re thrilled to congratulate @StFrancis_LI on performing the first #ShockwaveC2Aero cases! Huge thanks to Dr Rich Shlofmitz, Dr Evan Shlofmitz (@ESHLOF), and Dr Allen Jeremias (@DrAllenJ) for these milestone cases. U.S. Interventionists, stay tuned to learn more about
Tweet media one
0
5
12
@ShockwaveIVL
Shockwave Medical
6 days
COSIRA II MILESTONE ALERT: 1st Randomized Patient in the UK . Congratulations to Drs. Rasha Al-Lamee & Shayna Chotai and the team at Hammersmith Hospital of the Imperial College Healthcare NHS Trust in London for joining the growing number of #COSIRAII enrolling sites and
Tweet media one
0
1
2
@ShockwaveIVL
Shockwave Medical
7 days
Correction: Prof Niels Thue Olsen is not a paid consultant of Shockwave Medical.
0
0
0
@ShockwaveIVL
Shockwave Medical
7 days
Correction: Prof Niels Thue Olsen is not a paid consultant of Shockwave Medical.
0
0
0
@ShockwaveIVL
Shockwave Medical
7 days
Correction: Prof Niels Thue Olsen is not a paid consultant of Shockwave Medical.
0
0
0
@ShockwaveIVL
Shockwave Medical
7 days
Correction: Prof Niels Thue Olsen is not a paid consultant of Shockwave Medical.
0
0
0
@ShockwaveIVL
Shockwave Medical
11 days
Next week, don’t miss the #ShockwaveIVL symposium at #ASVS Singapore! Join this engaging discussion to learn from expert physicians how Shockwave IVL is transforming care for patients with complex PAD. US Rx only. ISI  
Tweet media one
0
1
2
@ShockwaveIVL
Shockwave Medical
11 days
Lead investigator Prof @ThueOlsen dives deeper into the methodology and results of the BALI randomized, superiority trial in this EuroPCR 2025 roundtable discussion with Profs @FlavioRibichini and @mbmcentegart. Watch now: All physicians are paid
Tweet media one
2
1
3
@ShockwaveIVL
Shockwave Medical
12 days
First of its kind study: EMPOWER CAD. Dr. @mbmcentegart and Dr. @AlexandraLansky discuss how quality of life as an indicator of treatment success is making waves in clinical studies and the importance of it. #EMPOWERCAD demonstrates significant improvement of quality of life in
0
1
4
@ShockwaveIVL
Shockwave Medical
12 days
Congratulations to Drs. Elaine K. Moen & Bryce S. Lynn and the team at Ascension St. Vincent in Indianapolis, Indiana for joining the growing number of #COSIRAII enrolling sites and completing their 1st single arm patient for the trial. To learn more about the COSIRA-II trial
Tweet media one
1
2
3
@ShockwaveIVL
Shockwave Medical
13 days
Act now to save limbs and lives! We’re happy to partner with @LegsMatter and lower limb healthcare experts for a webinar on 3 Sept discussing: . 🦵Current challenges in PAD diagnosis and treatment .🦵The case for greater Government recognition and investment in PAD .🦵Benefits
Tweet media one
0
0
3
@ShockwaveIVL
Shockwave Medical
13 days
Not all chest pain is the same. Refractory angina is often mistaken for other conditions like acid reflux or anxiety. Do your patients know the difference?. Spread the word about these warning signs — early recognition can improve treatment success and patient wellbeing.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
1
2
@ShockwaveIVL
Shockwave Medical
14 days
TONIGHT at 8 pm ET! Dive into BTK disease best practices, treatment options and more by joining our webinar, Complex BTK Disease: What Works and What Doesn’t. Don’t miss your chance to participate in an interactive discussion with Drs. @DrJayMohan, George Chrysant and @JDCorlMD.
Tweet media one
0
0
5
@ShockwaveIVL
Shockwave Medical
16 days
BTK disease is notoriously challenging to treat — but these guys know how to crack it. Join Drs. @DrJayMohan, George Chrysant and @JDCorlMD as they discuss BTK best practices based on their extensive real-world experience. Register for our webinar today and mark your calendars
Tweet media one
2
0
2